Lotan Y - Search Results

1

Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.

Shariat SF, Herman MP, Casella R, Lotan Y, Karam JA, Stenman UH. Shariat SF, et al. Among authors: lotan y. Eur Urol. 2005 Sep;48(3):424-31. doi: 10.1016/j.eururo.2005.04.034. Eur Urol. 2005. PMID: 15963628

2

Cost-effectiveness of a modified care protocol substituting bladder tumor markers for cystoscopy for the followup of patients with transitional cell carcinoma of the bladder: a decision analytical approach.

Lotan Y, Roehrborn CG. Lotan Y, et al. J Urol. 2002 Jan;167(1):75-9. J Urol. 2002. PMID: 11743279

3

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses.

Lotan Y, Roehrborn CG. Lotan Y, et al. Urology. 2003 Jan;61(1):109-18; discussion 118. doi: 10.1016/s0090-4295(02)02136-2. Urology. 2003. PMID: 12559279 Review.

4

Histopathology of surgically managed renal tumors: analysis of a contemporary series.

Duchene DA, Lotan Y, Cadeddu JA, Sagalowsky AI, Koeneman KS. Duchene DA, et al. Among authors: lotan y. Urology. 2003 Nov;62(5):827-30. doi: 10.1016/s0090-4295(03)00658-7. Urology. 2003. PMID: 14624902 Review.

5

Factors influencing the outcomes of penile prosthesis surgery at a teaching institution.

Lotan Y, Roehrborn CG, McConnell JD, Hendin BN. Lotan Y, et al. Urology. 2003 Nov;62(5):918-21. doi: 10.1016/s0090-4295(03)00665-4. Urology. 2003. PMID: 14624920 Review.

6

The effects of radio frequency ablation on renal function and blood pressure.

Johnson DB, Taylor GD, Lotan Y, Sagalowsky AI, Koenemann KS, Cadeddu JA. Johnson DB, et al. Among authors: lotan y. J Urol. 2003 Dec;170(6 Pt 1):2234-6. doi: 10.1097/01.ju.0000096265.22657.e8. J Urol. 2003. PMID: 14634386

7

Survivin expression is associated with features of biologically aggressive prostate carcinoma.

Shariat SF, Lotan Y, Saboorian H, Khoddami SM, Roehrborn CG, Slawin KM, Ashfaq R. Shariat SF, et al. Among authors: lotan y. Cancer. 2004 Feb 15;100(4):751-7. doi: 10.1002/cncr.20039. Cancer. 2004. PMID: 14770431 Free article.

8

The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy.

Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, Sagalowsky AI, McConnell JD, Roehrborn CG. Lotan Y, et al. J Urol. 2004 Jun;171(6 Pt 1):2209-14. doi: 10.1097/01.ju.0000127730.78973.fe. J Urol. 2004. PMID: 15126787

9

Predictive value of primary Gleason pattern 4 in patients with Gleason score 7 tumours treated with radical prostatectomy.

Khoddami SM, Shariat SF, Lotan Y, Saboorian H, McConnell JD, Sagalowsky AI, Roehrborn CG, Koeneman KS. Khoddami SM, et al. Among authors: lotan y. BJU Int. 2004 Jul;94(1):42-6. doi: 10.1111/j.1464-410X.2004.04898.x. BJU Int. 2004. PMID: 15217428

10

Cost analysis of laparoscopic versus open orchiopexy in the management of unilateral nonpalpable testicles.

Lorenzo AJ, Samuelson ML, Docimo SG, Baker LA, Lotan Y. Lorenzo AJ, et al. Among authors: lotan y. J Urol. 2004 Aug;172(2):712-6. doi: 10.1097/01.ju.0000130572.64035.7b. J Urol. 2004. PMID: 15247768

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

767 results

Search Page

Filters